When analyzing individuals with partially remitted MDD (n = 17), we obtained the same results such that there were no differences in mean [oxy-Hb] values during VFT between pre- and post-treatments for all 52 channels (Fig. 3). The gene discussed is GSTM1; the disease is major depressive disorder.